recombinant human acid sphingomyelinase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human acid sphingomyelinase, covering 2015-07-30 to 2015-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency Patients [Phase 1]